Abstract
Priothera has raised about $35 million in series A financing to develop drugs for acute myeloid leukemia (AML). The Dublin-based company will use the funds to test mocravimod in a clinical trial of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have